114,47 €
127,19 €
-10% with code: EXTRA
Essentials of Atrial Fibrillation
Essentials of Atrial Fibrillation
114,47
127,19 €
  • We will send in 10–14 business days.
This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. ​Atrial fibrillation (AF) affects an estimated 1-2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stro…
127.19
  • SAVE -10% with code: EXTRA

Essentials of Atrial Fibrillation (e-book) (used book) | bookbook.eu

Reviews

Description

This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. ​Atrial fibrillation (AF) affects an estimated 1-2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events.

EXTRA 10 % discount with code: EXTRA

114,47
127,19 €
We will send in 10–14 business days.

The promotion ends in 22d.16:53:44

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,27 Book Euros!?
  • Author: Yee Guan Yap
  • Publisher:
  • ISBN-10: 185873438X
  • ISBN-13: 9781858734385
  • Format: 12.2 x 19.6 x 0.5 cm, minkšti viršeliai
  • Language: English English

This handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. ​Atrial fibrillation (AF) affects an estimated 1-2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patients developing AF is expected to double in the next five decades, leading to increased incidence of stroke, heart failure and other serious thromboembolic events.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)